UPS is quickly expanding its healthcare logistics business with the acquisition of Smartways Logistics, an Australian company that offers time-critical courier services for the healthcare industry. The deal, announced Tuesday, will strengthen the group’s position in Australia and New Zealand and expand its healthcare network across the Asia-Pacific region.

The transaction is expected to close in the first half of 2027 and will provide UPS with greater access to the expanding Oceania healthcare logistics market. Also, UPS’s global transport infrastructure will be available to Smartways customers to provide more integrated shipping solutions for cross-border healthcare supply chains.

The move aligns with UPS’s larger strategy of targeting industries with complex operational needs and higher margins. Healthcare has become one of its key growth drivers, particularly as medical products become increasingly personalized, time sensitive and difficult to transport without compromising their integrity. The increase in direct to patient deliveries is also creating new requirements for specialized storage, handling and distribution.

The healthcare logistics market is expected to grow at 6% annually. UPS’s own performance demonstrates the importance of this segment, as healthcare revenue reached $3 billion for the third straight quarter in Q3, putting the company on pace to generate more than $12 billion in healthcare revenue for the year.

Strategic investments in health care logistics

Smartways is the most recent in a string of strategic buys that have strengthened UPS Healthcare’s capabilities globally.

In April 2025 UPS acquired Canada’s Andlauer Healthcare Group, a cold-chain logistics specialist for the health-care industry. The company acquired Frigo-Trans and its sister company BPL earlier this year, both of which handle temperature-controlled warehousing and transportation for pharmaceutical and biotechnology companies across Europe.

UPS made other acquisitions, including Bomi and MNX, and these deals continue the company’s expansion of its specialized logistics offering.

Today, UPS Healthcare operates some 20 million square feet of pharmaceutical-certified warehouse space, backed by a large network of temperature-controlled facilities. The portfolio encompasses inventory management, cold chain packaging and transportation, medical device warehousing and fulfillment, and logistics services to laboratories and clinical trials.

This acquisition strategy has been accompanied by infrastructure development. During the past two years, UPS has invested $48 million in 27 refrigerated truck cross-dock facilities worldwide. This investment was designed to meet the rising demand from pharmaceutical manufacturers, medical laboratories and biotechnology companies for reliable temperature-controlled transportation and storage of sensitive products.

More investment for Asia-Pacific network

The Smartways transaction is also part of a broader initiative to strengthen UPS Healthcare’s operational capabilities throughout Asia-Pacific.

In addition to acquisitions, the company has also invested in its regional infrastructure to support growing trade flows and improve the movement of temperature sensitive healthcare products. Major projects will include a greatly expanded hub at Clark Airport in the Philippines and an upgraded air terminal in Seoul, South Korea. Both facilities also have extra refrigerated warehouse capacity to support pharmaceuticals that require controlled temperatures.

Smartways have a proven regional healthcare operation

Smartways is owned by private equity firm, The Riverside Company, and operates in Australia and New Zealand with more than 350 drivers.

The company’s primary business is same-day and next-day transportation within the healthcare industry, including medical devices and equipment, life sciences products, clinical trial materials and radiopharmaceuticals.

Provision of express freight to hospitals on behalf of suppliers of medical devices and equipment in key medical specialties is a core activity. Smartways also offers contract logistics such as inventory management and distribution services.

The financial terms of the acquisition have not been officially announced, but The Australian Financial Review reported Sunday that UPS had offered A$600 million (about US$405 million).

This acquisition is part of UPS’s strategy to build a more comprehensive healthcare logistics network that combines specialized regional expertise with global transportation capabilities.